RT Journal Article
SR Electronic
T1 Psoriasis Outcome Measures: A Report from the GRAPPA 2012 Annual Meeting
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1428
OP 1433
DO 10.3899/jrheum.130456
VO 40
IS 8
A1 Alice B. Gottlieb
A1 April W. Armstrong
YR 2013
UL http://www.jrheum.org/content/40/8/1428.abstract
AB Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.